Welcome and Introduction: Update on International Consensus/Guidelines for GHD Management
Insights of IGF-1 as a biomarker in GHD therapy
LAGH in paediatric GHD: final 4-year results , switch and treatment outcomes
Real-world clinical practice and Globe-Reg registry data with LAGH in paediatric GHD
Questions & Answers
Final remarks